KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Inventory Average (2016 - 2025)

Sarepta Therapeutics has reported Inventory Average over the past 10 years, most recently at $996.0 million for Q4 2025.

  • Quarterly results put Inventory Average at $996.0 million for Q4 2025, up 51.37% from a year ago — trailing twelve months through Dec 2025 was $996.0 million (up 51.37% YoY), and the annual figure for FY2025 was $832.4 million, up 55.17%.
  • Inventory Average for Q4 2025 was $996.0 million at Sarepta Therapeutics, down from $1.0 billion in the prior quarter.
  • Over the last five years, Inventory Average for SRPT hit a ceiling of $1.0 billion in Q3 2025 and a floor of $192.6 million in Q1 2022.
  • Median Inventory Average over the past 5 years was $266.6 million (2021), compared with a mean of $428.7 million.
  • Biggest five-year swings in Inventory Average: dropped 22.96% in 2022 and later skyrocketed 142.88% in 2025.
  • Sarepta Therapeutics' Inventory Average stood at $237.3 million in 2021, then decreased by 10.43% to $212.6 million in 2022, then surged by 33.33% to $283.4 million in 2023, then skyrocketed by 132.13% to $657.9 million in 2024, then skyrocketed by 51.37% to $996.0 million in 2025.
  • The last three reported values for Inventory Average were $996.0 million (Q4 2025), $1.0 billion (Q3 2025), and $967.7 million (Q2 2025) per Business Quant data.